The study found that while small primary tumors had a healthy population of antitumor effector CD8+ T lymphocytes, recurrent tumors had an immunosuppressive condition consisting in expanded populations of tumor-associated macrophages (TAMs), Treg cells, and pro-tumoral cytokines that inhibited cytotoxic CD8+ T lymphocytes. Here, CD8A is linked to neoplasm.